-
BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023
Authors:
Anahita Fathi Kazerooni,
Nastaran Khalili,
Xinyang Liu,
Debanjan Haldar,
Zhifan Jiang,
Anna Zapaishchykova,
Julija Pavaine,
Lubdha M. Shah,
Blaise V. Jones,
Nakul Sheth,
Sanjay P. Prabhu,
Aaron S. McAllister,
Wenxin Tu,
Khanak K. Nandolia,
Andres F. Rodriguez,
Ibraheem Salman Shaikh,
Mariana Sanchez Montano,
Hollie Anne Lai,
Maruf Adewole,
Jake Albrecht,
Udunna Anazodo,
Hannah Anderson,
Syed Muhammed Anwar,
Alejandro Aristizabal,
Sina Bagheri
, et al. (55 additional authors not shown)
Abstract:
Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%. The development of new treatments is dependent upon multi-institutional collaborative clinical trials requiring reproducible and accurate centralized response assessment. We present the results of the BraTS-PEDs 2023 cha…
▽ More
Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%. The development of new treatments is dependent upon multi-institutional collaborative clinical trials requiring reproducible and accurate centralized response assessment. We present the results of the BraTS-PEDs 2023 challenge, the first Brain Tumor Segmentation (BraTS) challenge focused on pediatric brain tumors. This challenge utilized data acquired from multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. BraTS-PEDs 2023 aimed to evaluate volumetric segmentation algorithms for pediatric brain gliomas from magnetic resonance imaging using standardized quantitative performance evaluation metrics employed across the BraTS 2023 challenges. The top-performing AI approaches for pediatric tumor analysis included ensembles of nnU-Net and Swin UNETR, Auto3DSeg, or nnU-Net with a self-supervised framework. The BraTSPEDs 2023 challenge fostered collaboration between clinicians (neuro-oncologists, neuroradiologists) and AI/imaging scientists, promoting faster data sharing and the development of automated volumetric analysis techniques. These advancements could significantly benefit clinical trials and improve the care of children with brain tumors.
△ Less
Submitted 16 July, 2024; v1 submitted 11 July, 2024;
originally announced July 2024.
-
Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
Authors:
Dominic LaBella,
Ujjwal Baid,
Omaditya Khanna,
Shan McBurney-Lin,
Ryan McLean,
Pierre Nedelec,
Arif Rashid,
Nourel Hoda Tahon,
Talissa Altes,
Radhika Bhalerao,
Yaseen Dhemesh,
Devon Godfrey,
Fathi Hilal,
Scott Floyd,
Anastasia Janas,
Anahita Fathi Kazerooni,
John Kirkpatrick,
Collin Kent,
Florian Kofler,
Kevin Leu,
Nazanin Maleki,
Bjoern Menze,
Maxence Pajot,
Zachary J. Reitman,
Jeffrey D. Rudie
, et al. (96 additional authors not shown)
Abstract:
We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning…
▽ More
We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning automated segmentation models using image data from the largest multi-institutional systematically expert annotated multilabel multi-sequence meningioma MRI dataset to date, which included 1000 training set cases, 141 validation set cases, and 283 hidden test set cases. Each case included T2, T2/FLAIR, T1, and T1Gd brain MRI sequences with associated tumor compartment labels delineating enhancing tumor, non-enhancing tumor, and surrounding non-enhancing T2/FLAIR hyperintensity. Participant automated segmentation models were evaluated and ranked based on a scoring system evaluating lesion-wise metrics including dice similarity coefficient (DSC) and 95% Hausdorff Distance. The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor, respectively and a corresponding average DSC of 0.899, 0.904, and 0.871, respectively. These results serve as state-of-the-art benchmarks for future pre-operative meningioma automated segmentation algorithms. Additionally, we found that 1286 of 1424 cases (90.3%) had at least 1 compartment voxel abutting the edge of the skull-stripped image edge, which requires further investigation into optimal pre-processing face anonymization steps.
△ Less
Submitted 15 May, 2024;
originally announced May 2024.
-
Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning
Authors:
Junhao Wen,
Mathilde Antoniades,
Zhijian Yang,
Gyujoon Hwang,
Ioanna Skampardoni,
Rongguang Wang,
Christos Davatzikos
Abstract:
Machine learning has been increasingly used to obtain individualized neuroimaging signatures for disease diagnosis, prognosis, and response to treatment in neuropsychiatric and neurodegenerative disorders. Therefore, it has contributed to a better understanding of disease heterogeneity by identifying disease subtypes that present significant differences in various brain phenotypic measures. In thi…
▽ More
Machine learning has been increasingly used to obtain individualized neuroimaging signatures for disease diagnosis, prognosis, and response to treatment in neuropsychiatric and neurodegenerative disorders. Therefore, it has contributed to a better understanding of disease heterogeneity by identifying disease subtypes that present significant differences in various brain phenotypic measures. In this review, we first present a systematic literature overview of studies using machine learning and multimodal MRI to unravel disease heterogeneity in various neuropsychiatric and neurodegenerative disorders, including Alzheimer disease, schizophrenia, major depressive disorder, autism spectrum disorder, multiple sclerosis, as well as their potential in transdiagnostic settings. Subsequently, we summarize relevant machine learning methodologies and discuss an emerging paradigm which we call dimensional neuroimaging endophenotype (DNE). DNE dissects the neurobiological heterogeneity of neuropsychiatric and neurodegenerative disorders into a low dimensional yet informative, quantitative brain phenotypic representation, serving as a robust intermediate phenotype (i.e., endophenotype) largely reflecting underlying genetics and etiology. Finally, we discuss the potential clinical implications of the current findings and envision future research avenues.
△ Less
Submitted 17 January, 2024;
originally announced January 2024.
-
MedShapeNet -- A Large-Scale Dataset of 3D Medical Shapes for Computer Vision
Authors:
Jianning Li,
Zongwei Zhou,
Jiancheng Yang,
Antonio Pepe,
Christina Gsaxner,
Gijs Luijten,
Chongyu Qu,
Tiezheng Zhang,
Xiaoxi Chen,
Wenxuan Li,
Marek Wodzinski,
Paul Friedrich,
Kangxian Xie,
Yuan Jin,
Narmada Ambigapathy,
Enrico Nasca,
Naida Solak,
Gian Marco Melito,
Viet Duc Vu,
Afaque R. Memon,
Christopher Schlachta,
Sandrine De Ribaupierre,
Rajnikant Patel,
Roy Eagleson,
Xiaojun Chen
, et al. (132 additional authors not shown)
Abstract:
Prior to the deep learning era, shape was commonly used to describe the objects. Nowadays, state-of-the-art (SOTA) algorithms in medical imaging are predominantly diverging from computer vision, where voxel grids, meshes, point clouds, and implicit surface models are used. This is seen from numerous shape-related publications in premier vision conferences as well as the growing popularity of Shape…
▽ More
Prior to the deep learning era, shape was commonly used to describe the objects. Nowadays, state-of-the-art (SOTA) algorithms in medical imaging are predominantly diverging from computer vision, where voxel grids, meshes, point clouds, and implicit surface models are used. This is seen from numerous shape-related publications in premier vision conferences as well as the growing popularity of ShapeNet (about 51,300 models) and Princeton ModelNet (127,915 models). For the medical domain, we present a large collection of anatomical shapes (e.g., bones, organs, vessels) and 3D models of surgical instrument, called MedShapeNet, created to facilitate the translation of data-driven vision algorithms to medical applications and to adapt SOTA vision algorithms to medical problems. As a unique feature, we directly model the majority of shapes on the imaging data of real patients. As of today, MedShapeNet includes 23 dataset with more than 100,000 shapes that are paired with annotations (ground truth). Our data is freely accessible via a web interface and a Python application programming interface (API) and can be used for discriminative, reconstructive, and variational benchmarks as well as various applications in virtual, augmented, or mixed reality, and 3D printing. Exemplary, we present use cases in the fields of classification of brain tumors, facial and skull reconstructions, multi-class anatomy completion, education, and 3D printing. In future, we will extend the data and improve the interfaces. The project pages are: https://medshapenet.ikim.nrw/ and https://github.com/Jianningli/medshapenet-feedback
△ Less
Submitted 12 December, 2023; v1 submitted 30 August, 2023;
originally announced August 2023.
-
Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience
Authors:
Rongguang Wang,
Guray Erus,
Pratik Chaudhari,
Christos Davatzikos
Abstract:
Machine learning (ML) has shown great promise for revolutionizing a number of areas, including healthcare. However, it is also facing a reproducibility crisis, especially in medicine. ML models that are carefully constructed from and evaluated on a training set might not generalize well on data from different patient populations or acquisition instrument settings and protocols. We tackle this prob…
▽ More
Machine learning (ML) has shown great promise for revolutionizing a number of areas, including healthcare. However, it is also facing a reproducibility crisis, especially in medicine. ML models that are carefully constructed from and evaluated on a training set might not generalize well on data from different patient populations or acquisition instrument settings and protocols. We tackle this problem in the context of neuroimaging of Alzheimer's disease (AD), schizophrenia (SZ) and brain aging. We develop a weighted empirical risk minimization approach that optimally combines data from a source group, e.g., subjects are stratified by attributes such as sex, age group, race and clinical cohort to make predictions on a target group, e.g., other sex, age group, etc. using a small fraction (10%) of data from the target group. We apply this method to multi-source data of 15,363 individuals from 20 neuroimaging studies to build ML models for diagnosis of AD and SZ, and estimation of brain age. We found that this approach achieves substantially better accuracy than existing domain adaptation techniques: it obtains area under curve greater than 0.95 for AD classification, area under curve greater than 0.7 for SZ classification and mean absolute error less than 5 years for brain age prediction on all target groups, achieving robustness to variations of scanners, protocols, and demographic or clinical characteristics. In some cases, it is even better than training on all data from the target group, because it leverages the diversity and size of a larger training set. We also demonstrate the utility of our models for prognostic tasks such as predicting disease progression in individuals with mild cognitive impairment. Critically, our brain age prediction models lead to new clinical insights regarding correlations with neurophysiological tests.
△ Less
Submitted 6 August, 2023;
originally announced August 2023.
-
The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn)
Authors:
Hongwei Bran Li,
Gian Marco Conte,
Syed Muhammad Anwar,
Florian Kofler,
Ivan Ezhov,
Koen van Leemput,
Marie Piraud,
Maria Diaz,
Byrone Cole,
Evan Calabrese,
Jeff Rudie,
Felix Meissen,
Maruf Adewole,
Anastasia Janas,
Anahita Fathi Kazerooni,
Dominic LaBella,
Ahmed W. Moawad,
Keyvan Farahani,
James Eddy,
Timothy Bergquist,
Verena Chung,
Russell Takeshi Shinohara,
Farouk Dako,
Walter Wiggins,
Zachary Reitman
, et al. (43 additional authors not shown)
Abstract:
Automated brain tumor segmentation methods have become well-established and reached performance levels offering clear clinical utility. These methods typically rely on four input magnetic resonance imaging (MRI) modalities: T1-weighted images with and without contrast enhancement, T2-weighted images, and FLAIR images. However, some sequences are often missing in clinical practice due to time const…
▽ More
Automated brain tumor segmentation methods have become well-established and reached performance levels offering clear clinical utility. These methods typically rely on four input magnetic resonance imaging (MRI) modalities: T1-weighted images with and without contrast enhancement, T2-weighted images, and FLAIR images. However, some sequences are often missing in clinical practice due to time constraints or image artifacts, such as patient motion. Consequently, the ability to substitute missing modalities and gain segmentation performance is highly desirable and necessary for the broader adoption of these algorithms in the clinical routine. In this work, we present the establishment of the Brain MR Image Synthesis Benchmark (BraSyn) in conjunction with the Medical Image Computing and Computer-Assisted Intervention (MICCAI) 2023. The primary objective of this challenge is to evaluate image synthesis methods that can realistically generate missing MRI modalities when multiple available images are provided. The ultimate aim is to facilitate automated brain tumor segmentation pipelines. The image dataset used in the benchmark is diverse and multi-modal, created through collaboration with various hospitals and research institutions.
△ Less
Submitted 28 June, 2023; v1 submitted 15 May, 2023;
originally announced May 2023.
-
The Brain Tumor Segmentation (BraTS) Challenge 2023: Local Synthesis of Healthy Brain Tissue via Inpainting
Authors:
Florian Kofler,
Felix Meissen,
Felix Steinbauer,
Robert Graf,
Eva Oswald,
Ezequiel de da Rosa,
Hongwei Bran Li,
Ujjwal Baid,
Florian Hoelzl,
Oezguen Turgut,
Izabela Horvath,
Diana Waldmannstetter,
Christina Bukas,
Maruf Adewole,
Syed Muhammad Anwar,
Anastasia Janas,
Anahita Fathi Kazerooni,
Dominic LaBella,
Ahmed W Moawad,
Keyvan Farahani,
James Eddy,
Timothy Bergquist,
Verena Chung,
Russell Takeshi Shinohara,
Farouk Dako
, et al. (43 additional authors not shown)
Abstract:
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with a scan that is already pathological. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantees for images featuring lesions. Examples include…
▽ More
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with a scan that is already pathological. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantees for images featuring lesions. Examples include but are not limited to algorithms for brain anatomy parcellation, tissue segmentation, and brain extraction. To solve this dilemma, we introduce the BraTS 2023 inpainting challenge. Here, the participants' task is to explore inpainting techniques to synthesize healthy brain scans from lesioned ones. The following manuscript contains the task formulation, dataset, and submission procedure. Later it will be updated to summarize the findings of the challenge. The challenge is organized as part of the BraTS 2023 challenge hosted at the MICCAI 2023 conference in Vancouver, Canada.
△ Less
Submitted 9 August, 2023; v1 submitted 15 May, 2023;
originally announced May 2023.
-
Gene-SGAN: a method for discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clustering
Authors:
Zhijian Yang,
Junhao Wen,
Ahmed Abdulkadir,
Yuhan Cui,
Guray Erus,
Elizabeth Mamourian,
Randa Melhem,
Dhivya Srinivasan,
Sindhuja T. Govindarajan,
Jiong Chen,
Mohamad Habes,
Colin L. Masters,
Paul Maruff,
Jurgen Fripp,
Luigi Ferrucci,
Marilyn S. Albert,
Sterling C. Johnson,
John C. Morris,
Pamela LaMontagne,
Daniel S. Marcus,
Tammie L. S. Benzinger,
David A. Wolk,
Li Shen,
Jingxuan Bao,
Susan M. Resnick
, et al. (3 additional authors not shown)
Abstract:
Disease heterogeneity has been a critical challenge for precision diagnosis and treatment, especially in neurologic and neuropsychiatric diseases. Many diseases can display multiple distinct brain phenotypes across individuals, potentially reflecting disease subtypes that can be captured using MRI and machine learning methods. However, biological interpretability and treatment relevance are limite…
▽ More
Disease heterogeneity has been a critical challenge for precision diagnosis and treatment, especially in neurologic and neuropsychiatric diseases. Many diseases can display multiple distinct brain phenotypes across individuals, potentially reflecting disease subtypes that can be captured using MRI and machine learning methods. However, biological interpretability and treatment relevance are limited if the derived subtypes are not associated with genetic drivers or susceptibility factors. Herein, we describe Gene-SGAN - a multi-view, weakly-supervised deep clustering method - which dissects disease heterogeneity by jointly considering phenotypic and genetic data, thereby conferring genetic correlations to the disease subtypes and associated endophenotypic signatures. We first validate the generalizability, interpretability, and robustness of Gene-SGAN in semi-synthetic experiments. We then demonstrate its application to real multi-site datasets from 28,858 individuals, deriving subtypes of Alzheimer's disease and brain endophenotypes associated with hypertension, from MRI and SNP data. Derived brain phenotypes displayed significant differences in neuroanatomical patterns, genetic determinants, biological and clinical biomarkers, indicating potentially distinct underlying neuropathologic processes, genetic drivers, and susceptibility factors. Overall, Gene-SGAN is broadly applicable to disease subtyping and endophenotype discovery, and is herein tested on disease-related, genetically-driven neuroimaging phenotypes.
△ Less
Submitted 25 January, 2023;
originally announced January 2023.
-
Deep Learning Based Detection of Enlarged Perivascular Spaces on Brain MRI
Authors:
Tanweer Rashid,
Hangfan Liu,
Jeffrey B. Ware,
Karl Li,
Jose Rafael Romero,
Elyas Fadaee,
Ilya M. Nasrallah,
Saima Hilal,
R. Nick Bryan,
Timothy M. Hughes,
Christos Davatzikos,
Lenore Launer,
Sudha Seshadri,
Susan R. Heckbert,
Mohamad Habes
Abstract:
BACKGROUND AND PURPOSE: Deep learning has been demonstrated effective in many neuroimaging applications. However, in many scenarios, the number of imaging sequences capturing information related to small vessel disease lesions is insufficient to support data-driven techniques. Additionally, cohort-based studies may not always have the optimal or essential imaging sequences for accurate lesion dete…
▽ More
BACKGROUND AND PURPOSE: Deep learning has been demonstrated effective in many neuroimaging applications. However, in many scenarios, the number of imaging sequences capturing information related to small vessel disease lesions is insufficient to support data-driven techniques. Additionally, cohort-based studies may not always have the optimal or essential imaging sequences for accurate lesion detection. Therefore, it is necessary to determine which imaging sequences are crucial for precise detection. This study introduces a novel deep learning framework to detect enlarged perivascular spaces (ePVS) and aims to find the optimal combination of MRI sequences for deep learning-based quantification. MATERIALS AND METHODS: We implemented an effective lightweight U-Net adapted for ePVS detection and comprehensively investigated different combinations of information from SWI, FLAIR, T1-weighted (T1w), and T2-weighted (T2w) MRI sequences. The training data included 21 participants, which were randomly selected from the MESA cohort. Participants had ePVS 683 lesions on average. For T1w, T2w, and FLAIR images, the MESA study collected 3D isotropic MRI scans at six different sites with Siemens scanners. Our training data included participants from all these sites and all the scanner models, and the proposed model was applied to the whole brain instead of selective regions. RESULTS: The experimental results showed that T2w MRI is the most important for accurate ePVS detection, and the incorporation of SWI, FLAIR and T1w MRI in the deep neural network had minor improvements in accuracy and resulted in the highest sensitivity and precision (sensitivity =0.82, precision =0.83). The proposed method achieved comparable accuracy at a minimal time cost compared to manual reading.
△ Less
Submitted 14 October, 2022; v1 submitted 27 September, 2022;
originally announced September 2022.
-
Applications of Generative Adversarial Networks in Neuroimaging and Clinical Neuroscience
Authors:
Rongguang Wang,
Vishnu Bashyam,
Zhijian Yang,
Fanyang Yu,
Vasiliki Tassopoulou,
Sai Spandana Chintapalli,
Ioanna Skampardoni,
Lasya P. Sreepada,
Dushyant Sahoo,
Konstantina Nikita,
Ahmed Abdulkadir,
Junhao Wen,
Christos Davatzikos
Abstract:
Generative adversarial networks (GANs) are one powerful type of deep learning models that have been successfully utilized in numerous fields. They belong to a broader family called generative methods, which generate new data with a probabilistic model by learning sample distribution from real examples. In the clinical context, GANs have shown enhanced capabilities in capturing spatially complex, n…
▽ More
Generative adversarial networks (GANs) are one powerful type of deep learning models that have been successfully utilized in numerous fields. They belong to a broader family called generative methods, which generate new data with a probabilistic model by learning sample distribution from real examples. In the clinical context, GANs have shown enhanced capabilities in capturing spatially complex, nonlinear, and potentially subtle disease effects compared to traditional generative methods. This review appraises the existing literature on the applications of GANs in imaging studies of various neurological conditions, including Alzheimer's disease, brain tumors, brain aging, and multiple sclerosis. We provide an intuitive explanation of various GAN methods for each application and further discuss the main challenges, open questions, and promising future directions of leveraging GANs in neuroimaging. We aim to bridge the gap between advanced deep learning methods and neurology research by highlighting how GANs can be leveraged to support clinical decision making and contribute to a better understanding of the structural and functional patterns of brain diseases.
△ Less
Submitted 29 January, 2023; v1 submitted 14 June, 2022;
originally announced June 2022.
-
Bias in Machine Learning Models Can Be Significantly Mitigated by Careful Training: Evidence from Neuroimaging Studies
Authors:
Rongguang Wang,
Pratik Chaudhari,
Christos Davatzikos
Abstract:
Despite the great promise that machine learning has offered in many fields of medicine, it has also raised concerns about potential biases and poor generalization across genders, age distributions, races and ethnicities, hospitals, and data acquisition equipment and protocols. In the current study, and in the context of three brain diseases, we provide evidence which suggests that when properly tr…
▽ More
Despite the great promise that machine learning has offered in many fields of medicine, it has also raised concerns about potential biases and poor generalization across genders, age distributions, races and ethnicities, hospitals, and data acquisition equipment and protocols. In the current study, and in the context of three brain diseases, we provide evidence which suggests that when properly trained, machine learning models can generalize well across diverse conditions and do not necessarily suffer from bias. Specifically, by using multi-study magnetic resonance imaging consortia for diagnosing Alzheimer's disease, schizophrenia, and autism spectrum disorder, we find that well-trained models have a high area-under-the-curve (AUC) on subjects across different subgroups pertaining to attributes such as gender, age, racial groups, and different clinical studies and are unbiased under multiple fairness metrics such as demographic parity difference, equalized odds difference, equal opportunity difference etc. We find that models that incorporate multi-source data from demographic, clinical, genetic factors and cognitive scores are also unbiased. These models have better predictive AUC across subgroups than those trained only with imaging features but there are also situations when these additional features do not help.
△ Less
Submitted 30 January, 2023; v1 submitted 26 May, 2022;
originally announced May 2022.
-
Surreal-GAN:Semi-Supervised Representation Learning via GAN for uncovering heterogeneous disease-related imaging patterns
Authors:
Zhijian Yang,
Junhao Wen,
Christos Davatzikos
Abstract:
A plethora of machine learning methods have been applied to imaging data, enabling the construction of clinically relevant imaging signatures of neurological and neuropsychiatric diseases. Oftentimes, such methods don't explicitly model the heterogeneity of disease effects, or approach it via nonlinear models that are not interpretable. Moreover, unsupervised methods may parse heterogeneity that i…
▽ More
A plethora of machine learning methods have been applied to imaging data, enabling the construction of clinically relevant imaging signatures of neurological and neuropsychiatric diseases. Oftentimes, such methods don't explicitly model the heterogeneity of disease effects, or approach it via nonlinear models that are not interpretable. Moreover, unsupervised methods may parse heterogeneity that is driven by nuisance confounding factors that affect brain structure or function, rather than heterogeneity relevant to a pathology of interest. On the other hand, semi-supervised clustering methods seek to derive a dichotomous subtype membership, ignoring the truth that disease heterogeneity spatially and temporally extends along a continuum. To address the aforementioned limitations, herein, we propose a novel method, termed Surreal-GAN (Semi-SUpeRvised ReprEsentAtion Learning via GAN). Using cross-sectional imaging data, Surreal-GAN dissects underlying disease-related heterogeneity under the principle of semi-supervised clustering (cluster mappings from normal control to patient), proposes a continuously dimensional representation, and infers the disease severity of patients at individual level along each dimension. The model first learns a transformation function from normal control (CN) domain to the patient (PT) domain with latent variables controlling transformation directions. An inverse mapping function together with regularization on function continuity, pattern orthogonality and monotonicity was also imposed to make sure that the transformation function captures necessarily meaningful imaging patterns with clinical significance. We first validated the model through extensive semi-synthetic experiments, and then demonstrate its potential in capturing biologically plausible imaging patterns in Alzheimer's disease (AD).
△ Less
Submitted 9 May, 2022;
originally announced May 2022.
-
Federated Learning Enables Big Data for Rare Cancer Boundary Detection
Authors:
Sarthak Pati,
Ujjwal Baid,
Brandon Edwards,
Micah Sheller,
Shih-Han Wang,
G Anthony Reina,
Patrick Foley,
Alexey Gruzdev,
Deepthi Karkada,
Christos Davatzikos,
Chiharu Sako,
Satyam Ghodasara,
Michel Bilello,
Suyash Mohan,
Philipp Vollmuth,
Gianluca Brugnara,
Chandrakanth J Preetha,
Felix Sahm,
Klaus Maier-Hein,
Maximilian Zenk,
Martin Bendszus,
Wolfgang Wick,
Evan Calabrese,
Jeffrey Rudie,
Javier Villanueva-Meyer
, et al. (254 additional authors not shown)
Abstract:
Although machine learning (ML) has shown promise in numerous domains, there are concerns about generalizability to out-of-sample data. This is currently addressed by centrally sharing ample, and importantly diverse, data from multiple sites. However, such centralization is challenging to scale (or even not feasible) due to various limitations. Federated ML (FL) provides an alternative to train acc…
▽ More
Although machine learning (ML) has shown promise in numerous domains, there are concerns about generalizability to out-of-sample data. This is currently addressed by centrally sharing ample, and importantly diverse, data from multiple sites. However, such centralization is challenging to scale (or even not feasible) due to various limitations. Federated ML (FL) provides an alternative to train accurate and generalizable ML models, by only sharing numerical model updates. Here we present findings from the largest FL study to-date, involving data from 71 healthcare institutions across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, utilizing the largest dataset of such patients ever used in the literature (25,256 MRI scans from 6,314 patients). We demonstrate a 33% improvement over a publicly trained model to delineate the surgically targetable tumor, and 23% improvement over the tumor's entire extent. We anticipate our study to: 1) enable more studies in healthcare informed by large and diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further quantitative analyses for glioblastoma via performance optimization of our consensus model for eventual public release, and 3) demonstrate the effectiveness of FL at such scale and task complexity as a paradigm shift for multi-site collaborations, alleviating the need for data sharing.
△ Less
Submitted 25 April, 2022; v1 submitted 22 April, 2022;
originally announced April 2022.
-
Robust Hierarchical Patterns for identifying MDD patients: A Multisite Study
Authors:
Dushyant Sahoo,
Mathilde Antoniades,
Cynthia H. Y. Fu,
Christos Davatzikos
Abstract:
Many supervised machine learning frameworks have been proposed for disease classification using functional magnetic resonance imaging (fMRI) data, producing important biomarkers. More recently, data pooling has flourished, making the result generalizable across a large population. But, this success depends on the population diversity and variability introduced due to the pooling of the data that i…
▽ More
Many supervised machine learning frameworks have been proposed for disease classification using functional magnetic resonance imaging (fMRI) data, producing important biomarkers. More recently, data pooling has flourished, making the result generalizable across a large population. But, this success depends on the population diversity and variability introduced due to the pooling of the data that is not a primary research interest. Here, we look at hierarchical Sparse Connectivity Patterns (hSCPs) as biomarkers for major depressive disorder (MDD). We propose a novel model based on hSCPs to predict MDD patients from functional connectivity matrices extracted from resting-state fMRI data. Our model consists of three coupled terms. The first term decomposes connectivity matrices into hierarchical low-rank sparse components corresponding to synchronous patterns across the human brain. These components are then combined via patient-specific weights capturing heterogeneity in the data. The second term is a classification loss that uses the patient-specific weights to classify MDD patients from healthy ones. Both of these terms are combined with the third term, a robustness loss function to improve the reproducibility of hSCPs. This reduces the variability introduced due to site and population diversity (age and sex) on the predictive accuracy and pattern stability in a large dataset pooled from five different sites. Our results show the impact of diversity on prediction performance. Our model can reduce diversity and improve the predictive and generalizing capability of the components. Finally, our results show that our proposed model can robustly identify clinically relevant patterns characteristic of MDD with high reproducibility.
△ Less
Submitted 22 February, 2022;
originally announced February 2022.
-
Subtyping brain diseases from imaging data
Authors:
Junhao Wen,
Erdem Varol,
Zhijian Yang,
Gyujoon Hwang,
Dominique Dwyer,
Anahita Fathi Kazerooni,
Paris Alexandros Lalousis,
Christos Davatzikos
Abstract:
The imaging community has increasingly adopted machine learning (ML) methods to provide individualized imaging signatures related to disease diagnosis, prognosis, and response to treatment. Clinical neuroscience and cancer imaging have been two areas in which ML has offered particular promise. However, many neurologic and neuropsychiatric diseases, as well as cancer, are often heterogeneous in ter…
▽ More
The imaging community has increasingly adopted machine learning (ML) methods to provide individualized imaging signatures related to disease diagnosis, prognosis, and response to treatment. Clinical neuroscience and cancer imaging have been two areas in which ML has offered particular promise. However, many neurologic and neuropsychiatric diseases, as well as cancer, are often heterogeneous in terms of their clinical manifestations, neuroanatomical patterns or genetic underpinnings. Therefore, in such cases, seeking a single disease signature might be ineffectual in delivering individualized precision diagnostics. The current chapter focuses on ML methods, especially semi-supervised clustering, that seek disease subtypes using imaging data. Work from Alzheimer Disease and its prodromal stages, psychosis, depression, autism, and brain cancer are discussed. Our goal is to provide the readers with a broad overview in terms of methodology and clinical applications.
△ Less
Submitted 16 February, 2022;
originally announced February 2022.
-
QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation - Analysis of Ranking Scores and Benchmarking Results
Authors:
Raghav Mehta,
Angelos Filos,
Ujjwal Baid,
Chiharu Sako,
Richard McKinley,
Michael Rebsamen,
Katrin Datwyler,
Raphael Meier,
Piotr Radojewski,
Gowtham Krishnan Murugesan,
Sahil Nalawade,
Chandan Ganesh,
Ben Wagner,
Fang F. Yu,
Baowei Fei,
Ananth J. Madhuranthakam,
Joseph A. Maldjian,
Laura Daza,
Catalina Gomez,
Pablo Arbelaez,
Chengliang Dai,
Shuo Wang,
Hadrien Reynaud,
Yuan-han Mo,
Elsa Angelini
, et al. (67 additional authors not shown)
Abstract:
Deep learning (DL) models have provided state-of-the-art performance in various medical imaging benchmarking challenges, including the Brain Tumor Segmentation (BraTS) challenges. However, the task of focal pathology multi-compartment segmentation (e.g., tumor and lesion sub-regions) is particularly challenging, and potential errors hinder translating DL models into clinical workflows. Quantifying…
▽ More
Deep learning (DL) models have provided state-of-the-art performance in various medical imaging benchmarking challenges, including the Brain Tumor Segmentation (BraTS) challenges. However, the task of focal pathology multi-compartment segmentation (e.g., tumor and lesion sub-regions) is particularly challenging, and potential errors hinder translating DL models into clinical workflows. Quantifying the reliability of DL model predictions in the form of uncertainties could enable clinical review of the most uncertain regions, thereby building trust and paving the way toward clinical translation. Several uncertainty estimation methods have recently been introduced for DL medical image segmentation tasks. Developing scores to evaluate and compare the performance of uncertainty measures will assist the end-user in making more informed decisions. In this study, we explore and evaluate a score developed during the BraTS 2019 and BraTS 2020 task on uncertainty quantification (QU-BraTS) and designed to assess and rank uncertainty estimates for brain tumor multi-compartment segmentation. This score (1) rewards uncertainty estimates that produce high confidence in correct assertions and those that assign low confidence levels at incorrect assertions, and (2) penalizes uncertainty measures that lead to a higher percentage of under-confident correct assertions. We further benchmark the segmentation uncertainties generated by 14 independent participating teams of QU-BraTS 2020, all of which also participated in the main BraTS segmentation task. Overall, our findings confirm the importance and complementary value that uncertainty estimates provide to segmentation algorithms, highlighting the need for uncertainty quantification in medical image analyses. Finally, in favor of transparency and reproducibility, our evaluation code is made publicly available at: https://github.com/RagMeh11/QU-BraTS.
△ Less
Submitted 23 August, 2022; v1 submitted 19 December, 2021;
originally announced December 2021.
-
The Brain Tumor Sequence Registration (BraTS-Reg) Challenge: Establishing Correspondence Between Pre-Operative and Follow-up MRI Scans of Diffuse Glioma Patients
Authors:
Bhakti Baheti,
Satrajit Chakrabarty,
Hamed Akbari,
Michel Bilello,
Benedikt Wiestler,
Julian Schwarting,
Evan Calabrese,
Jeffrey Rudie,
Syed Abidi,
Mina Mousa,
Javier Villanueva-Meyer,
Brandon K. K. Fields,
Florian Kofler,
Russell Takeshi Shinohara,
Juan Eugenio Iglesias,
Tony C. W. Mok,
Albert C. S. Chung,
Marek Wodzinski,
Artur Jurgas,
Niccolo Marini,
Manfredo Atzori,
Henning Muller,
Christoph Grobroehmer,
Hanna Siebert,
Lasse Hansen
, et al. (48 additional authors not shown)
Abstract:
Registration of longitudinal brain MRI scans containing pathologies is challenging due to dramatic changes in tissue appearance. Although there has been progress in developing general-purpose medical image registration techniques, they have not yet attained the requisite precision and reliability for this task, highlighting its inherent complexity. Here we describe the Brain Tumor Sequence Registr…
▽ More
Registration of longitudinal brain MRI scans containing pathologies is challenging due to dramatic changes in tissue appearance. Although there has been progress in developing general-purpose medical image registration techniques, they have not yet attained the requisite precision and reliability for this task, highlighting its inherent complexity. Here we describe the Brain Tumor Sequence Registration (BraTS-Reg) challenge, as the first public benchmark environment for deformable registration algorithms focusing on estimating correspondences between pre-operative and follow-up scans of the same patient diagnosed with a diffuse brain glioma. The BraTS-Reg data comprise de-identified multi-institutional multi-parametric MRI (mpMRI) scans, curated for size and resolution according to a canonical anatomical template, and divided into training, validation, and testing sets. Clinical experts annotated ground truth (GT) landmark points of anatomical locations distinct across the temporal domain. Quantitative evaluation and ranking were based on the Median Euclidean Error (MEE), Robustness, and the determinant of the Jacobian of the displacement field. The top-ranked methodologies yielded similar performance across all evaluation metrics and shared several methodological commonalities, including pre-alignment, deep neural networks, inverse consistency analysis, and test-time instance optimization per-case basis as a post-processing step. The top-ranked method attained the MEE at or below that of the inter-rater variability for approximately 60% of the evaluated landmarks, underscoring the scope for further accuracy and robustness improvements, especially relative to human experts. The aim of BraTS-Reg is to continue to serve as an active resource for research, with the data and online evaluation tools accessible at https://bratsreg.github.io/.
△ Less
Submitted 17 April, 2024; v1 submitted 13 December, 2021;
originally announced December 2021.
-
Multidimensional representations in late-life depression: convergence in neuroimaging, cognition, clinical symptomatology and genetics
Authors:
Junhao Wen,
Cynthia H. Y. Fu,
Duygu Tosun,
Yogasudha Veturi,
Zhijian Yang,
Ahmed Abdulkadir,
Elizabeth Mamourian,
Dhivya Srinivasan,
Jingxuan Bao,
Guray Erus,
Haochang Shou,
Mohamad Habes,
Jimit Doshi,
Erdem Varol,
Scott R Mackin,
Aristeidis Sotiras,
Yong Fan,
Andrew J. Saykin,
Yvette I. Sheline,
Li Shen,
Marylyn D. Ritchie,
David A. Wolk,
Marilyn Albert,
Susan M. Resnick,
Christos Davatzikos
Abstract:
Late-life depression (LLD) is characterized by considerable heterogeneity in clinical manifestation. Unraveling such heterogeneity would aid in elucidating etiological mechanisms and pave the road to precision and individualized medicine. We sought to delineate, cross-sectionally and longitudinally, disease-related heterogeneity in LLD linked to neuroanatomy, cognitive functioning, clinical sympto…
▽ More
Late-life depression (LLD) is characterized by considerable heterogeneity in clinical manifestation. Unraveling such heterogeneity would aid in elucidating etiological mechanisms and pave the road to precision and individualized medicine. We sought to delineate, cross-sectionally and longitudinally, disease-related heterogeneity in LLD linked to neuroanatomy, cognitive functioning, clinical symptomatology, and genetic profiles. Multimodal data from a multicentre sample (N=996) were analyzed. A semi-supervised clustering method (HYDRA) was applied to regional grey matter (GM) brain volumes to derive dimensional representations. Two dimensions were identified, which accounted for the LLD-related heterogeneity in voxel-wise GM maps, white matter (WM) fractional anisotropy (FA), neurocognitive functioning, clinical phenotype, and genetics. Dimension one (Dim1) demonstrated relatively preserved brain anatomy without WM disruptions relative to healthy controls. In contrast, dimension two (Dim2) showed widespread brain atrophy and WM integrity disruptions, along with cognitive impairment and higher depression severity. Moreover, one de novo independent genetic variant (rs13120336) was significantly associated with Dim 1 but not with Dim 2. Notably, the two dimensions demonstrated significant SNP-based heritability of 18-27% within the general population (N=12,518 in UKBB). Lastly, in a subset of individuals having longitudinal measurements, Dim2 demonstrated a more rapid longitudinal decrease in GM and brain age, and was more likely to progress to Alzheimers disease, compared to Dim1 (N=1,413 participants and 7,225 scans from ADNI, BLSA, and BIOCARD datasets).
△ Less
Submitted 25 October, 2021; v1 submitted 20 October, 2021;
originally announced October 2021.
-
Disentangling Alzheimer's disease neurodegeneration from typical brain aging using machine learning
Authors:
Gyujoon Hwang,
Ahmed Abdulkadir,
Guray Erus,
Mohamad Habes,
Raymond Pomponio,
Haochang Shou,
Jimit Doshi,
Elizabeth Mamourian,
Tanweer Rashid,
Murat Bilgel,
Yong Fan,
Aristeidis Sotiras,
Dhivya Srinivasan,
John C. Morris,
Daniel Marcus,
Marilyn S. Albert,
Nick R. Bryan,
Susan M. Resnick,
Ilya M. Nasrallah,
Christos Davatzikos,
David A. Wolk
Abstract:
Neuroimaging biomarkers that distinguish between typical brain aging and Alzheimer's disease (AD) are valuable for determining how much each contributes to cognitive decline. Machine learning models can derive multi-variate brain change patterns related to the two processes, including the SPARE-AD (Spatial Patterns of Atrophy for Recognition of Alzheimer's Disease) and SPARE-BA (of Brain Aging) in…
▽ More
Neuroimaging biomarkers that distinguish between typical brain aging and Alzheimer's disease (AD) are valuable for determining how much each contributes to cognitive decline. Machine learning models can derive multi-variate brain change patterns related to the two processes, including the SPARE-AD (Spatial Patterns of Atrophy for Recognition of Alzheimer's Disease) and SPARE-BA (of Brain Aging) investigated herein. However, substantial overlap between brain regions affected in the two processes confounds measuring them independently. We present a methodology toward disentangling the two. T1-weighted MRI images of 4,054 participants (48-95 years) with AD, mild cognitive impairment (MCI), or cognitively normal (CN) diagnoses from the iSTAGING (Imaging-based coordinate SysTem for AGIng and NeurodeGenerative diseases) consortium were analyzed. First, a subset of AD patients and CN adults were selected based purely on clinical diagnoses to train SPARE-BA1 (regression of age using CN individuals) and SPARE-AD1 (classification of CN versus AD). Second, analogous groups were selected based on clinical and molecular markers to train SPARE-BA2 and SPARE-AD2: amyloid-positive (A+) AD continuum group (consisting of A+AD, A+MCI, and A+ and tau-positive CN individuals) and amyloid-negative (A-) CN group. Finally, the combined group of the AD continuum and A-/CN individuals was used to train SPARE-BA3, with the intention to estimate brain age regardless of AD-related brain changes. Disentangled SPARE models derived brain patterns that were more specific to the two types of the brain changes. Correlation between the SPARE-BA and SPARE-AD was significantly reduced. Correlation of disentangled SPARE-AD was non-inferior to the molecular measurements and to the number of APOE4 alleles, but was less to AD-related psychometric test scores, suggesting contribution of advanced brain aging to these scores.
△ Less
Submitted 8 September, 2021;
originally announced September 2021.
-
The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation and Radiogenomic Classification
Authors:
Ujjwal Baid,
Satyam Ghodasara,
Suyash Mohan,
Michel Bilello,
Evan Calabrese,
Errol Colak,
Keyvan Farahani,
Jayashree Kalpathy-Cramer,
Felipe C. Kitamura,
Sarthak Pati,
Luciano M. Prevedello,
Jeffrey D. Rudie,
Chiharu Sako,
Russell T. Shinohara,
Timothy Bergquist,
Rong Chai,
James Eddy,
Julia Elliott,
Walter Reade,
Thomas Schaffter,
Thomas Yu,
Jiaxin Zheng,
Ahmed W. Moawad,
Luiz Otavio Coelho,
Olivia McDonnell
, et al. (78 additional authors not shown)
Abstract:
The BraTS 2021 challenge celebrates its 10th anniversary and is jointly organized by the Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR), and the Medical Image Computing and Computer Assisted Interventions (MICCAI) society. Since its inception, BraTS has been focusing on being a common benchmarking venue for brain glioma segmentation algorithms, with wel…
▽ More
The BraTS 2021 challenge celebrates its 10th anniversary and is jointly organized by the Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR), and the Medical Image Computing and Computer Assisted Interventions (MICCAI) society. Since its inception, BraTS has been focusing on being a common benchmarking venue for brain glioma segmentation algorithms, with well-curated multi-institutional multi-parametric magnetic resonance imaging (mpMRI) data. Gliomas are the most common primary malignancies of the central nervous system, with varying degrees of aggressiveness and prognosis. The RSNA-ASNR-MICCAI BraTS 2021 challenge targets the evaluation of computational algorithms assessing the same tumor compartmentalization, as well as the underlying tumor's molecular characterization, in pre-operative baseline mpMRI data from 2,040 patients. Specifically, the two tasks that BraTS 2021 focuses on are: a) the segmentation of the histologically distinct brain tumor sub-regions, and b) the classification of the tumor's O[6]-methylguanine-DNA methyltransferase (MGMT) promoter methylation status. The performance evaluation of all participating algorithms in BraTS 2021 will be conducted through the Sage Bionetworks Synapse platform (Task 1) and Kaggle (Task 2), concluding in distributing to the top ranked participants monetary awards of $60,000 collectively.
△ Less
Submitted 12 September, 2021; v1 submitted 5 July, 2021;
originally announced July 2021.
-
Harmonization with Flow-based Causal Inference
Authors:
Rongguang Wang,
Pratik Chaudhari,
Christos Davatzikos
Abstract:
Heterogeneity in medical data, e.g., from data collected at different sites and with different protocols in a clinical study, is a fundamental hurdle for accurate prediction using machine learning models, as such models often fail to generalize well. This paper leverages a recently proposed normalizing-flow-based method to perform counterfactual inference upon a structural causal model (SCM), in o…
▽ More
Heterogeneity in medical data, e.g., from data collected at different sites and with different protocols in a clinical study, is a fundamental hurdle for accurate prediction using machine learning models, as such models often fail to generalize well. This paper leverages a recently proposed normalizing-flow-based method to perform counterfactual inference upon a structural causal model (SCM), in order to achieve harmonization of such data. A causal model is used to model observed effects (brain magnetic resonance imaging data) that result from known confounders (site, gender and age) and exogenous noise variables. Our formulation exploits the bijection induced by flow for the purpose of harmonization. We infer the posterior of exogenous variables, intervene on observations, and draw samples from the resultant SCM to obtain counterfactuals. This approach is evaluated extensively on multiple, large, real-world medical datasets and displayed better cross-domain generalization compared to state-of-the-art algorithms. Further experiments that evaluate the quality of confounder-independent data generated by our model using regression and classification tasks are provided.
△ Less
Submitted 10 July, 2021; v1 submitted 12 June, 2021;
originally announced June 2021.
-
Ensemble inversion for brain tumor growth models with mass effect
Authors:
Shashank Subramanian,
Klaudius Scheufele,
Naveen Himthani,
Christos Davatzikos,
George Biros
Abstract:
We propose a method for extracting physics-based biomarkers from a single multiparametric Magnetic Resonance Imaging (mpMRI) scan bearing a glioma tumor. We account for mass effect, the deformation of brain parenchyma due to the growing tumor, which on its own is an important radiographic feature but its automatic quantification remains an open problem. In particular, we calibrate a partial differ…
▽ More
We propose a method for extracting physics-based biomarkers from a single multiparametric Magnetic Resonance Imaging (mpMRI) scan bearing a glioma tumor. We account for mass effect, the deformation of brain parenchyma due to the growing tumor, which on its own is an important radiographic feature but its automatic quantification remains an open problem. In particular, we calibrate a partial differential equation (PDE) tumor growth model that captures mass effect, parameterized by a single scalar parameter, tumor proliferation, migration, while localizing the tumor initiation site. The single-scan calibration problem is severely ill-posed because the precancerous, healthy, brain anatomy is unknown. To address the ill-posedness, we introduce an ensemble inversion scheme that uses a number of normal subject brain templates as proxies for the healthy precancer subject anatomy. We verify our solver on a synthetic dataset and perform a retrospective analysis on a clinical dataset of 216 glioblastoma (GBM) patients. We analyze the reconstructions using our calibrated biophysical model and demonstrate that our solver provides both global and local quantitative measures of tumor biophysics and mass effect. We further highlight the improved performance in model calibration through the inclusion of mass effect in tumor growth models -- including mass effect in the model leads to 10% increase in average dice coefficients for patients with significant mass effect. We further evaluate our model by introducing novel biophysics-based features and using them for survival analysis. Our preliminary analysis suggests that including such features can improve patient stratification and survival prediction.
△ Less
Submitted 10 June, 2021;
originally announced June 2021.
-
Learning Robust Hierarchical Patterns of Human Brain across Many fMRI Studies
Authors:
Dushyant Sahoo,
Christos Davatzikos
Abstract:
Resting-state fMRI has been shown to provide surrogate biomarkers for the analysis of various diseases. In addition, fMRI data helps in understanding the brain's functional working during resting state and task-induced activity. To improve the statistical power of biomarkers and the understanding mechanism of the brain, pooling of multi-center studies has become increasingly popular. But pooling t…
▽ More
Resting-state fMRI has been shown to provide surrogate biomarkers for the analysis of various diseases. In addition, fMRI data helps in understanding the brain's functional working during resting state and task-induced activity. To improve the statistical power of biomarkers and the understanding mechanism of the brain, pooling of multi-center studies has become increasingly popular. But pooling the data from multiple sites introduces variations due to hardware, software, and environment. In this paper, we look at the estimation problem of hierarchical Sparsity Connectivity Patterns (hSCPs) in fMRI data acquired on multiple sites. We introduce a simple yet effective matrix factorization based formulation to reduce site-related effects while preserving biologically relevant variations. We leverage adversarial learning in the unsupervised regime to improve the reproducibility of the components. Experiments on simulated datasets display that the proposed method can estimate components with improved accuracy and reproducibility. We also demonstrate the improved reproducibility of the components while preserving age-related variation on a real dataset compiled from multiple sites.
△ Less
Submitted 7 October, 2021; v1 submitted 13 May, 2021;
originally announced May 2021.
-
The Federated Tumor Segmentation (FeTS) Challenge
Authors:
Sarthak Pati,
Ujjwal Baid,
Maximilian Zenk,
Brandon Edwards,
Micah Sheller,
G. Anthony Reina,
Patrick Foley,
Alexey Gruzdev,
Jason Martin,
Shadi Albarqouni,
Yong Chen,
Russell Taki Shinohara,
Annika Reinke,
David Zimmerer,
John B. Freymann,
Justin S. Kirby,
Christos Davatzikos,
Rivka R. Colen,
Aikaterini Kotrotsou,
Daniel Marcus,
Mikhail Milchenko,
Arash Nazeri,
Hassan Fathallah-Shaykh,
Roland Wiest,
Andras Jakab
, et al. (7 additional authors not shown)
Abstract:
This manuscript describes the first challenge on Federated Learning, namely the Federated Tumor Segmentation (FeTS) challenge 2021. International challenges have become the standard for validation of biomedical image analysis methods. However, the actual performance of participating (even the winning) algorithms on "real-world" clinical data often remains unclear, as the data included in challenge…
▽ More
This manuscript describes the first challenge on Federated Learning, namely the Federated Tumor Segmentation (FeTS) challenge 2021. International challenges have become the standard for validation of biomedical image analysis methods. However, the actual performance of participating (even the winning) algorithms on "real-world" clinical data often remains unclear, as the data included in challenges are usually acquired in very controlled settings at few institutions. The seemingly obvious solution of just collecting increasingly more data from more institutions in such challenges does not scale well due to privacy and ownership hurdles. Towards alleviating these concerns, we are proposing the FeTS challenge 2021 to cater towards both the development and the evaluation of models for the segmentation of intrinsically heterogeneous (in appearance, shape, and histology) brain tumors, namely gliomas. Specifically, the FeTS 2021 challenge uses clinically acquired, multi-institutional magnetic resonance imaging (MRI) scans from the BraTS 2020 challenge, as well as from various remote independent institutions included in the collaborative network of a real-world federation (https://www.fets.ai/). The goals of the FeTS challenge are directly represented by the two included tasks: 1) the identification of the optimal weight aggregation approach towards the training of a consensus model that has gained knowledge via federated learning from multiple geographically distinct institutions, while their data are always retained within each institution, and 2) the federated evaluation of the generalizability of brain tumor segmentation models "in the wild", i.e. on data from institutional distributions that were not part of the training datasets.
△ Less
Submitted 13 May, 2021; v1 submitted 12 May, 2021;
originally announced May 2021.
-
Extraction of Hierarchical Functional Connectivity Components in human brain using Adversarial Learning
Authors:
Dushyant Sahoo,
Christos Davatzikos
Abstract:
The estimation of sparse hierarchical components reflecting patterns of the brain's functional connectivity from rsfMRI data can contribute to our understanding of the brain's functional organization, and can lead to biomarkers of diseases. However, inter-scanner variations and other confounding factors pose a challenge to the robust and reproducible estimation of functionally-interpretable brain…
▽ More
The estimation of sparse hierarchical components reflecting patterns of the brain's functional connectivity from rsfMRI data can contribute to our understanding of the brain's functional organization, and can lead to biomarkers of diseases. However, inter-scanner variations and other confounding factors pose a challenge to the robust and reproducible estimation of functionally-interpretable brain networks, and especially to reproducible biomarkers. Moreover, the brain is believed to be organized hierarchically, and hence single-scale decompositions miss this hierarchy. The paper aims to use current advancements in adversarial learning to estimate interpretable hierarchical patterns in the human brain using rsfMRI data, which are robust to "adversarial effects" such as inter-scanner variations. We write the estimation problem as a minimization problem and solve it using alternating updates. Extensive experiments on simulation and a real-world dataset show high reproducibility of the components compared to other well-known methods.
△ Less
Submitted 20 April, 2021;
originally announced April 2021.
-
Embracing the Disharmony in Medical Imaging: A Simple and Effective Framework for Domain Adaptation
Authors:
Rongguang Wang,
Pratik Chaudhari,
Christos Davatzikos
Abstract:
Domain shift, the mismatch between training and testing data characteristics, causes significant degradation in the predictive performance in multi-source imaging scenarios. In medical imaging, the heterogeneity of population, scanners and acquisition protocols at different sites presents a significant domain shift challenge and has limited the widespread clinical adoption of machine learning mode…
▽ More
Domain shift, the mismatch between training and testing data characteristics, causes significant degradation in the predictive performance in multi-source imaging scenarios. In medical imaging, the heterogeneity of population, scanners and acquisition protocols at different sites presents a significant domain shift challenge and has limited the widespread clinical adoption of machine learning models. Harmonization methods which aim to learn a representation of data invariant to these differences are the prevalent tools to address domain shift, but they typically result in degradation of predictive accuracy. This paper takes a different perspective of the problem: we embrace this disharmony in data and design a simple but effective framework for tackling domain shift. The key idea, based on our theoretical arguments, is to build a pretrained classifier on the source data and adapt this model to new data. The classifier can be fine-tuned for intra-site domain adaptation. We can also tackle situations where we do not have access to ground-truth labels on target data; we show how one can use auxiliary tasks for adaptation; these tasks employ covariates such as age, gender and race which are easy to obtain but nevertheless correlated to the main task. We demonstrate substantial improvements in both intra-site domain adaptation and inter-site domain generalization on large-scale real-world 3D brain MRI datasets for classifying Alzheimer's disease and schizophrenia.
△ Less
Submitted 20 December, 2021; v1 submitted 23 March, 2021;
originally announced March 2021.
-
GaNDLF: A Generally Nuanced Deep Learning Framework for Scalable End-to-End Clinical Workflows in Medical Imaging
Authors:
Sarthak Pati,
Siddhesh P. Thakur,
İbrahim Ethem Hamamcı,
Ujjwal Baid,
Bhakti Baheti,
Megh Bhalerao,
Orhun Güley,
Sofia Mouchtaris,
David Lang,
Spyridon Thermos,
Karol Gotkowski,
Camila González,
Caleb Grenko,
Alexander Getka,
Brandon Edwards,
Micah Sheller,
Junwen Wu,
Deepthi Karkada,
Ravi Panchumarthy,
Vinayak Ahluwalia,
Chunrui Zou,
Vishnu Bashyam,
Yuemeng Li,
Babak Haghighi,
Rhea Chitalia
, et al. (17 additional authors not shown)
Abstract:
Deep Learning (DL) has the potential to optimize machine learning in both the scientific and clinical communities. However, greater expertise is required to develop DL algorithms, and the variability of implementations hinders their reproducibility, translation, and deployment. Here we present the community-driven Generally Nuanced Deep Learning Framework (GaNDLF), with the goal of lowering these…
▽ More
Deep Learning (DL) has the potential to optimize machine learning in both the scientific and clinical communities. However, greater expertise is required to develop DL algorithms, and the variability of implementations hinders their reproducibility, translation, and deployment. Here we present the community-driven Generally Nuanced Deep Learning Framework (GaNDLF), with the goal of lowering these barriers. GaNDLF makes the mechanism of DL development, training, and inference more stable, reproducible, interpretable, and scalable, without requiring an extensive technical background. GaNDLF aims to provide an end-to-end solution for all DL-related tasks in computational precision medicine. We demonstrate the ability of GaNDLF to analyze both radiology and histology images, with built-in support for k-fold cross-validation, data augmentation, multiple modalities and output classes. Our quantitative performance evaluation on numerous use cases, anatomies, and computational tasks supports GaNDLF as a robust application framework for deployment in clinical workflows.
△ Less
Submitted 16 May, 2023; v1 submitted 25 February, 2021;
originally announced March 2021.
-
Disentangling brain heterogeneity via semi-supervised deep-learning and MRI: dimensional representations of Alzheimer's Disease
Authors:
Zhijian Yang,
Ilya M. Nasrallah,
Haochang Shou,
Junhao Wen,
Jimit Doshi,
Mohamad Habes,
Guray Erus,
Ahmed Abdulkadir,
Susan M. Resnick,
David Wolk,
Christos Davatzikos
Abstract:
Heterogeneity of brain diseases is a challenge for precision diagnosis/prognosis. We describe and validate Smile-GAN (SeMI-supervised cLustEring-Generative Adversarial Network), a novel semi-supervised deep-clustering method, which dissects neuroanatomical heterogeneity, enabling identification of disease subtypes via their imaging signatures relative to controls. When applied to MRIs (2 studies;…
▽ More
Heterogeneity of brain diseases is a challenge for precision diagnosis/prognosis. We describe and validate Smile-GAN (SeMI-supervised cLustEring-Generative Adversarial Network), a novel semi-supervised deep-clustering method, which dissects neuroanatomical heterogeneity, enabling identification of disease subtypes via their imaging signatures relative to controls. When applied to MRIs (2 studies; 2,832 participants; 8,146 scans) including cognitively normal individuals and those with cognitive impairment and dementia, Smile-GAN identified 4 neurodegenerative patterns/axes: P1, normal anatomy and highest cognitive performance; P2, mild/diffuse atrophy and more prominent executive dysfunction; P3, focal medial temporal atrophy and relatively greater memory impairment; P4, advanced neurodegeneration. Further application to longitudinal data revealed two distinct progression pathways: P1$\rightarrow$P2$\rightarrow$P4 and P1$\rightarrow$P3$\rightarrow$P4. Baseline expression of these patterns predicted the pathway and rate of future neurodegeneration. Pattern expression offered better yet complementary performance in predicting clinical progression, compared to amyloid/tau. These deep-learning derived biomarkers offer promise for precision diagnostics and targeted clinical trial recruitment.
△ Less
Submitted 24 February, 2021;
originally announced February 2021.
-
Medical Image Harmonization Using Deep Learning Based Canonical Mapping: Toward Robust and Generalizable Learning in Imaging
Authors:
Vishnu M. Bashyam,
Jimit Doshi,
Guray Erus,
Dhivya Srinivasan,
Ahmed Abdulkadir,
Mohamad Habes,
Yong Fan,
Colin L. Masters,
Paul Maruff,
Chuanjun Zhuo,
Henry Völzke,
Sterling C. Johnson,
Jurgen Fripp,
Nikolaos Koutsouleris,
Theodore D. Satterthwaite,
Daniel H. Wolf,
Raquel E. Gur,
Ruben C. Gur,
John C. Morris,
Marilyn S. Albert,
Hans J. Grabe,
Susan M. Resnick,
R. Nick Bryan,
David A. Wolk,
Haochang Shou
, et al. (2 additional authors not shown)
Abstract:
Conventional and deep learning-based methods have shown great potential in the medical imaging domain, as means for deriving diagnostic, prognostic, and predictive biomarkers, and by contributing to precision medicine. However, these methods have yet to see widespread clinical adoption, in part due to limited generalization performance across various imaging devices, acquisition protocols, and pat…
▽ More
Conventional and deep learning-based methods have shown great potential in the medical imaging domain, as means for deriving diagnostic, prognostic, and predictive biomarkers, and by contributing to precision medicine. However, these methods have yet to see widespread clinical adoption, in part due to limited generalization performance across various imaging devices, acquisition protocols, and patient populations. In this work, we propose a new paradigm in which data from a diverse range of acquisition conditions are "harmonized" to a common reference domain, where accurate model learning and prediction can take place. By learning an unsupervised image to image canonical mapping from diverse datasets to a reference domain using generative deep learning models, we aim to reduce confounding data variation while preserving semantic information, thereby rendering the learning task easier in the reference domain. We test this approach on two example problems, namely MRI-based brain age prediction and classification of schizophrenia, leveraging pooled cohorts of neuroimaging MRI data spanning 9 sites and 9701 subjects. Our results indicate a substantial improvement in these tasks in out-of-sample data, even when training is restricted to a single site.
△ Less
Submitted 11 October, 2020;
originally announced October 2020.
-
A review of deep learning in medical imaging: Imaging traits, technology trends, case studies with progress highlights, and future promises
Authors:
S. Kevin Zhou,
Hayit Greenspan,
Christos Davatzikos,
James S. Duncan,
Bram van Ginneken,
Anant Madabhushi,
Jerry L. Prince,
Daniel Rueckert,
Ronald M. Summers
Abstract:
Since its renaissance, deep learning has been widely used in various medical imaging tasks and has achieved remarkable success in many medical imaging applications, thereby propelling us into the so-called artificial intelligence (AI) era. It is known that the success of AI is mostly attributed to the availability of big data with annotations for a single task and the advances in high performance…
▽ More
Since its renaissance, deep learning has been widely used in various medical imaging tasks and has achieved remarkable success in many medical imaging applications, thereby propelling us into the so-called artificial intelligence (AI) era. It is known that the success of AI is mostly attributed to the availability of big data with annotations for a single task and the advances in high performance computing. However, medical imaging presents unique challenges that confront deep learning approaches. In this survey paper, we first present traits of medical imaging, highlight both clinical needs and technical challenges in medical imaging, and describe how emerging trends in deep learning are addressing these issues. We cover the topics of network architecture, sparse and noisy labels, federating learning, interpretability, uncertainty quantification, etc. Then, we present several case studies that are commonly found in clinical practice, including digital pathology and chest, brain, cardiovascular, and abdominal imaging. Rather than presenting an exhaustive literature survey, we instead describe some prominent research highlights related to these case study applications. We conclude with a discussion and presentation of promising future directions.
△ Less
Submitted 5 March, 2021; v1 submitted 2 August, 2020;
originally announced August 2020.
-
A Deep Network for Joint Registration and Reconstruction of Images with Pathologies
Authors:
Xu Han,
Zhengyang Shen,
Zhenlin Xu,
Spyridon Bakas,
Hamed Akbari,
Michel Bilello,
Christos Davatzikos,
Marc Niethammer
Abstract:
Registration of images with pathologies is challenging due to tissue appearance changes and missing correspondences caused by the pathologies. Moreover, mass effects as observed for brain tumors may displace tissue, creating larger deformations over time than what is observed in a healthy brain. Deep learning models have successfully been applied to image registration to offer dramatic speed up an…
▽ More
Registration of images with pathologies is challenging due to tissue appearance changes and missing correspondences caused by the pathologies. Moreover, mass effects as observed for brain tumors may displace tissue, creating larger deformations over time than what is observed in a healthy brain. Deep learning models have successfully been applied to image registration to offer dramatic speed up and to use surrogate information (e.g., segmentations) during training. However, existing approaches focus on learning registration models using images from healthy patients. They are therefore not designed for the registration of images with strong pathologies for example in the context of brain tumors, and traumatic brain injuries. In this work, we explore a deep learning approach to register images with brain tumors to an atlas. Our model learns an appearance mapping from images with tumors to the atlas, while simultaneously predicting the transformation to atlas space. Using separate decoders, the network disentangles the tumor mass effect from the reconstruction of quasi-normal images. Results on both synthetic and real brain tumor scans show that our approach outperforms cost function masking for registration to the atlas and that reconstructed quasi-normal images can be used for better longitudinal registrations.
△ Less
Submitted 17 August, 2020;
originally announced August 2020.
-
MAGIC: Multi-scale Heterogeneity Analysis and Clustering for Brain Diseases
Authors:
Junhao Wen,
Erdem Varol,
Ganesh Chand,
Aristeidis Sotiras,
Christos Davatzikos
Abstract:
There is a growing amount of clinical, anatomical and functional evidence for the heterogeneous presentation of neuropsychiatric and neurodegenerative diseases such as schizophrenia and Alzheimers Disease (AD). Elucidating distinct subtypes of diseases allows a better understanding of neuropathogenesis and enables the possibility of developing targeted treatment programs. Recent semi-supervised cl…
▽ More
There is a growing amount of clinical, anatomical and functional evidence for the heterogeneous presentation of neuropsychiatric and neurodegenerative diseases such as schizophrenia and Alzheimers Disease (AD). Elucidating distinct subtypes of diseases allows a better understanding of neuropathogenesis and enables the possibility of developing targeted treatment programs. Recent semi-supervised clustering techniques have provided a data-driven way to understand disease heterogeneity. However, existing methods do not take into account that subtypes of the disease might present themselves at different spatial scales across the brain. Here, we introduce a novel method, MAGIC, to uncover disease heterogeneity by leveraging multi-scale clustering. We first extract multi-scale patterns of structural covariance (PSCs) followed by a semi-supervised clustering with double cyclic block-wise optimization across different scales of PSCs. We validate MAGIC using simulated heterogeneous neuroanatomical data and demonstrate its clinical potential by exploring the heterogeneity of AD using T1 MRI scans of 228 cognitively normal (CN) and 191 patients. Our results indicate two main subtypes of AD with distinct atrophy patterns that consist of both fine-scale atrophy in the hippocampus as well as large-scale atrophy in cortical regions. The evidence for the heterogeneity is further corroborated by the clinical evaluation of two subtypes, which indicates that there is a subpopulation of AD patients that tend to be younger and decline faster in cognitive performance relative to the other subpopulation, which tends to be older and maintains a relatively steady decline in cognitive abilities.
△ Less
Submitted 9 July, 2020; v1 submitted 1 July, 2020;
originally announced July 2020.
-
Smile-GANs: Semi-supervised clustering via GANs for dissecting brain disease heterogeneity from medical images
Authors:
Zhijian Yang,
Junhao Wen,
Christos Davatzikos
Abstract:
Machine learning methods applied to complex biomedical data has enabled the construction of disease signatures of diagnostic/prognostic value. However, less attention has been given to understanding disease heterogeneity. Semi-supervised clustering methods can address this problem by estimating multiple transformations from a (e.g. healthy) control (CN) group to a patient (PT) group, seeking to ca…
▽ More
Machine learning methods applied to complex biomedical data has enabled the construction of disease signatures of diagnostic/prognostic value. However, less attention has been given to understanding disease heterogeneity. Semi-supervised clustering methods can address this problem by estimating multiple transformations from a (e.g. healthy) control (CN) group to a patient (PT) group, seeking to capture the heterogeneity of underlying pathlogic processes. Herein, we propose a novel method, Smile-GANs (SeMi-supervIsed cLustEring via GANs), for semi-supervised clustering, and apply it to brain MRI scans. Smile-GANs first learns multiple distinct mappings by generating PT from CN, with each mapping characterizing one relatively distinct pathological pattern. Moreover, a clustering model is trained interactively with mapping functions to assign PT into corresponding subtype memberships. Using relaxed assumptions on PT/CN data distribution and imposing mapping non-linearity, Smile-GANs captures heterogeneous differences in distribution between the CN and PT domains. We first validate Smile-GANs using simulated data, subsequently on real data, by demonstrating its potential in characterizing heterogeneity in Alzheimer's Disease (AD) and its prodromal phases. The model was first trained using baseline MRIs from the ADNI2 database and then applied to longitudinal data from ADNI1 and BLSA. Four robust subtypes with distinct neuroanatomical patterns were discovered: 1) normal brain, 2) diffuse atrophy atypical of AD, 3) focal medial temporal lobe atrophy, 4) typical-AD. Further longitudinal analyses discover two distinct progressive pathways from prodromal to full AD: i) subtypes 1 - 2 - 4, and ii) subtypes 1 - 3 - 4. Although demonstrated on an important biomedical problem, Smile-GANs is general and can find application in many biomedical and other domains.
△ Less
Submitted 26 June, 2020;
originally announced June 2020.
-
Open Source Software Sustainability Models: Initial White Paper from the Informatics Technology for Cancer Research Sustainability and Industry Partnership Work Group
Authors:
Y. Ye,
R. D. Boyce,
M. K. Davis,
K. Elliston,
C. Davatzikos,
A. Fedorov,
J. C. Fillion-Robin,
I. Foster,
J. Gilbertson,
M. Heiskanen,
J. Klemm,
A. Lasso,
J. V. Miller,
M. Morgan,
S. Pieper,
B. Raumann,
B. Sarachan,
G. Savova,
J. C. Silverstein,
D. Taylor,
J. Zelnis,
G. Q. Zhang,
M. J. Becich
Abstract:
The Sustainability and Industry Partnership Work Group (SIP-WG) is a part of the National Cancer Institute Informatics Technology for Cancer Research (ITCR) program. The charter of the SIP-WG is to investigate options of long-term sustainability of open source software (OSS) developed by the ITCR, in part by developing a collection of business model archetypes that can serve as sustainability plan…
▽ More
The Sustainability and Industry Partnership Work Group (SIP-WG) is a part of the National Cancer Institute Informatics Technology for Cancer Research (ITCR) program. The charter of the SIP-WG is to investigate options of long-term sustainability of open source software (OSS) developed by the ITCR, in part by developing a collection of business model archetypes that can serve as sustainability plans for ITCR OSS development initiatives. The workgroup assembled models from the ITCR program, from other studies, and via engagement of its extensive network of relationships with other organizations (e.g., Chan Zuckerberg Initiative, Open Source Initiative and Software Sustainability Institute). This article reviews existing sustainability models and describes ten OSS use cases disseminated by the SIP-WG and others, and highlights five essential attributes (alignment with unmet scientific needs, dedicated development team, vibrant user community, feasible licensing model, and sustainable financial model) to assist academic software developers in achieving best practice in software sustainability.
△ Less
Submitted 1 January, 2020; v1 submitted 27 December, 2019;
originally announced December 2019.
-
DeepMRSeg: A convolutional deep neural network for anatomy and abnormality segmentation on MR images
Authors:
Jimit Doshi,
Guray Erus,
Mohamad Habes,
Christos Davatzikos
Abstract:
Segmentation has been a major task in neuroimaging. A large number of automated methods have been developed for segmenting healthy and diseased brain tissues. In recent years, deep learning techniques have attracted a lot of attention as a result of their high accuracy in different segmentation problems. We present a new deep learning based segmentation method, DeepMRSeg, that can be applied in a…
▽ More
Segmentation has been a major task in neuroimaging. A large number of automated methods have been developed for segmenting healthy and diseased brain tissues. In recent years, deep learning techniques have attracted a lot of attention as a result of their high accuracy in different segmentation problems. We present a new deep learning based segmentation method, DeepMRSeg, that can be applied in a generic way to a variety of segmentation tasks. The proposed architecture combines recent advances in the field of biomedical image segmentation and computer vision. We use a modified UNet architecture that takes advantage of multiple convolution filter sizes to achieve multi-scale feature extraction adaptive to the desired segmentation task. Importantly, our method operates on minimally processed raw MRI scan. We validated our method on a wide range of segmentation tasks, including white matter lesion segmentation, segmentation of deep brain structures and hippocampus segmentation. We provide code and pre-trained models to allow researchers apply our method on their own datasets.
△ Less
Submitted 3 July, 2019;
originally announced July 2019.
-
Extraction of hierarchical functional connectivity components in human brain using resting-state fMRI
Authors:
Dushyant Sahoo,
Theodore D. Satterthwaite,
Christos Davatzikos
Abstract:
The study of hierarchy in networks of the human brain has been of significant interest among the researchers as numerous studies have pointed out towards a functional hierarchical organization of the human brain. This paper provides a novel method for the extraction of hierarchical connectivity components in the human brain using resting-state fMRI. The method builds upon prior work of Sparse Conn…
▽ More
The study of hierarchy in networks of the human brain has been of significant interest among the researchers as numerous studies have pointed out towards a functional hierarchical organization of the human brain. This paper provides a novel method for the extraction of hierarchical connectivity components in the human brain using resting-state fMRI. The method builds upon prior work of Sparse Connectivity Patterns (SCPs) by introducing a hierarchy of sparse overlapping patterns. The components are estimated by deep factorization of correlation matrices generated from fMRI. The goal of the paper is to extract interpretable hierarchical patterns using correlation matrices where a low rank decomposition is formed by a linear combination of a high rank decomposition. We formulate the decomposition as a non-convex optimization problem and solve it using gradient descent algorithms with adaptive step size. We also provide a method for the warm start of the gradient descent using singular value decomposition. We demonstrate the effectiveness of the developed method on two different real-world datasets by showing that multi-scale hierarchical SCPs are reproducible between sub-samples and are more reproducible as compared to single scale patterns. We also compare our method with existing hierarchical community detection approaches. Our method also provides novel insight into the functional organization of the human brain.
△ Less
Submitted 7 December, 2020; v1 submitted 19 June, 2019;
originally announced June 2019.
-
Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge
Authors:
Spyridon Bakas,
Mauricio Reyes,
Andras Jakab,
Stefan Bauer,
Markus Rempfler,
Alessandro Crimi,
Russell Takeshi Shinohara,
Christoph Berger,
Sung Min Ha,
Martin Rozycki,
Marcel Prastawa,
Esther Alberts,
Jana Lipkova,
John Freymann,
Justin Kirby,
Michel Bilello,
Hassan Fathallah-Shaykh,
Roland Wiest,
Jan Kirschke,
Benedikt Wiestler,
Rivka Colen,
Aikaterini Kotrotsou,
Pamela Lamontagne,
Daniel Marcus,
Mikhail Milchenko
, et al. (402 additional authors not shown)
Abstract:
Gliomas are the most common primary brain malignancies, with different degrees of aggressiveness, variable prognosis and various heterogeneous histologic sub-regions, i.e., peritumoral edematous/invaded tissue, necrotic core, active and non-enhancing core. This intrinsic heterogeneity is also portrayed in their radio-phenotype, as their sub-regions are depicted by varying intensity profiles dissem…
▽ More
Gliomas are the most common primary brain malignancies, with different degrees of aggressiveness, variable prognosis and various heterogeneous histologic sub-regions, i.e., peritumoral edematous/invaded tissue, necrotic core, active and non-enhancing core. This intrinsic heterogeneity is also portrayed in their radio-phenotype, as their sub-regions are depicted by varying intensity profiles disseminated across multi-parametric magnetic resonance imaging (mpMRI) scans, reflecting varying biological properties. Their heterogeneous shape, extent, and location are some of the factors that make these tumors difficult to resect, and in some cases inoperable. The amount of resected tumor is a factor also considered in longitudinal scans, when evaluating the apparent tumor for potential diagnosis of progression. Furthermore, there is mounting evidence that accurate segmentation of the various tumor sub-regions can offer the basis for quantitative image analysis towards prediction of patient overall survival. This study assesses the state-of-the-art machine learning (ML) methods used for brain tumor image analysis in mpMRI scans, during the last seven instances of the International Brain Tumor Segmentation (BraTS) challenge, i.e., 2012-2018. Specifically, we focus on i) evaluating segmentations of the various glioma sub-regions in pre-operative mpMRI scans, ii) assessing potential tumor progression by virtue of longitudinal growth of tumor sub-regions, beyond use of the RECIST/RANO criteria, and iii) predicting the overall survival from pre-operative mpMRI scans of patients that underwent gross total resection. Finally, we investigate the challenge of identifying the best ML algorithms for each of these tasks, considering that apart from being diverse on each instance of the challenge, the multi-institutional mpMRI BraTS dataset has also been a continuously evolving/growing dataset.
△ Less
Submitted 23 April, 2019; v1 submitted 5 November, 2018;
originally announced November 2018.
-
CLAIRE: A distributed-memory solver for constrained large deformation diffeomorphic image registration
Authors:
Andreas Mang,
Amir Gholami,
Christos Davatzikos,
George Biros
Abstract:
With this work, we release CLAIRE, a distributed-memory implementation of an effective solver for constrained large deformation diffeomorphic image registration problems in three dimensions. We consider an optimal control formulation. We invert for a stationary velocity field that parameterizes the deformation map. Our solver is based on a globalized, preconditioned, inexact reduced space Gauss--N…
▽ More
With this work, we release CLAIRE, a distributed-memory implementation of an effective solver for constrained large deformation diffeomorphic image registration problems in three dimensions. We consider an optimal control formulation. We invert for a stationary velocity field that parameterizes the deformation map. Our solver is based on a globalized, preconditioned, inexact reduced space Gauss--Newton--Krylov scheme. We exploit state-of-the-art techniques in scientific computing to develop an effective solver that scales to thousands of distributed memory nodes on high-end clusters. We present the formulation, discuss algorithmic features, describe the software package, and introduce an improved preconditioner for the reduced space Hessian to speed up the convergence of our solver. We test registration performance on synthetic and real data. We demonstrate registration accuracy on several neuroimaging datasets. We compare the performance of our scheme against different flavors of the Demons algorithm for diffeomorphic image registration. We study convergence of our preconditioner and our overall algorithm. We report scalability results on state-of-the-art supercomputing platforms. We demonstrate that we can solve registration problems for clinically relevant data sizes in two to four minutes on a standard compute node with 20 cores, attaining excellent data fidelity. With the present work we achieve a speedup of (on average) 5$\times$ with a peak performance of up to 17$\times$ compared to our former work.
△ Less
Submitted 9 December, 2019; v1 submitted 13 August, 2018;
originally announced August 2018.
-
PDE-constrained optimization in medical image analysis
Authors:
Andreas Mang,
Amir Gholami,
Christos Davatzikos,
George Biros
Abstract:
PDE-constrained optimization problems find many applications in medical image analysis, for example, neuroimaging, cardiovascular imaging, and oncological imaging. We review related literature and give examples on the formulation, discretization, and numerical solution of PDE-constrained optimization problems for medical imaging. We discuss three examples. The first one is image registration. The…
▽ More
PDE-constrained optimization problems find many applications in medical image analysis, for example, neuroimaging, cardiovascular imaging, and oncological imaging. We review related literature and give examples on the formulation, discretization, and numerical solution of PDE-constrained optimization problems for medical imaging. We discuss three examples. The first one is image registration. The second one is data assimilation for brain tumor patients, and the third one data assimilation in cardiovascular imaging. The image registration problem is a classical task in medical image analysis and seeks to find pointwise correspondences between two or more images. The data assimilation problems use a PDE-constrained formulation to link a biophysical model to patient-specific data obtained from medical images. The associated optimality systems turn out to be sets of nonlinear, multicomponent PDEs that are challenging to solve in an efficient way.
The ultimate goal of our work is the design of inversion methods that integrate complementary data, and rigorously follow mathematical and physical principles, in an attempt to support clinical decision making. This requires reliable, high-fidelity algorithms with a short time-to-solution. This task is complicated by model and data uncertainties, and by the fact that PDE-constrained optimization problems are ill-posed in nature, and in general yield high-dimensional, severely ill-conditioned systems after discretization. These features make regularization, effective preconditioners, and iterative solvers that, in many cases, have to be implemented on distributed-memory architectures to be practical, a prerequisite. We showcase state-of-the-art techniques in scientific computing to tackle these challenges.
△ Less
Submitted 28 February, 2018;
originally announced March 2018.
-
Sparse Hierachical Extrapolated Parametric Methods for Cortical Data Analysis
Authors:
Nicolas Honnorat,
Christos Davatzikos
Abstract:
Many neuroimaging studies focus on the cortex, in order to benefit from better signal to noise ratios and reduced computational burden. Cortical data are usually projected onto a reference mesh, where subsequent analyses are carried out. Several multiscale approaches have been proposed for analyzing these surface data, such as spherical harmonics and graph wavelets. As far as we know, however, the…
▽ More
Many neuroimaging studies focus on the cortex, in order to benefit from better signal to noise ratios and reduced computational burden. Cortical data are usually projected onto a reference mesh, where subsequent analyses are carried out. Several multiscale approaches have been proposed for analyzing these surface data, such as spherical harmonics and graph wavelets. As far as we know, however, the hierarchical structure of the template icosahedral meshes used by most neuroimaging software has never been exploited for cortical data factorization. In this paper, we demonstrate how the structure of the ubiquitous icosahedral meshes can be exploited by data factorization methods such as sparse dictionary learning, and we assess the optimization speed-up offered by extrapolation methods in this context. By testing different sparsity-inducing norms, extrapolation methods, and factorization schemes, we compare the performances of eleven methods for analyzing four datasets: two structural and two functional MRI datasets obtained by processing the data publicly available for the hundred unrelated subjects of the Human Connectome Project. Our results demonstrate that, depending on the level of details requested, a speedup of several orders of magnitudes can be obtained.
△ Less
Submitted 27 April, 2017;
originally announced April 2017.